Form 4 Tracker
Xenon Pharmaceuticals Inc.
XENE

8 insider filings · Latest: Jun 1, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 3, 2026Jun 3 9:04 PMGary PatouDirector
Grant/Award
12,100$53.461,593(D)

View →

Jun 1, 2026Jun 3 9:04 PMGary PatouDirector
Option Exercise
2,6450(D)

View →

Jun 3, 2026Jun 3 9:04 PMPatrick MachadoDirector
Grant/Award
12,100$53.461,593(D)

View →

Jun 1, 2026Jun 3 9:04 PMPatrick MachadoDirector
Option Exercise
2,6450(D)

View →

Jun 3, 2026Jun 3 9:04 PMJustin D. GoverDirector
Grant/Award
12,100$53.461,593(D)

View →

Jun 1, 2026Jun 3 9:04 PMJustin D. GoverDirector
Option Exercise
2,6450(D)

View →

Jun 3, 2026Jun 3 9:04 PMElizabeth A. GarofaloDirector
Grant/Award
12,100$53.461,593(D)

View →

Jun 1, 2026Jun 3 9:04 PMElizabeth A. GarofaloDirector
Option Exercise
2,6450(D)

View →

Jun 3, 2026Jun 3 9:04 PMSteven GannonDirector
Grant/Award
12,100$53.461,593(D)

View →

Jun 1, 2026Jun 3 9:04 PMSteven GannonDirector
Option Exercise
2,6450(D)

View →

Jun 3, 2026Jun 3 9:03 PMGillian CannonDirector
Grant/Award
12,100$53.461,593(D)

View →

Jun 1, 2026Jun 3 9:03 PMGillian CannonDirector
Option Exercise
2,6450(D)

View →

Jun 3, 2026Jun 3 9:03 PMDawn SvoronosDirector
Grant/Award
12,100$53.461,593(D)

View →

Jun 1, 2026Jun 3 9:03 PMDawn SvoronosDirector
Option Exercise
2,6450(D)

View →

May 12, 2026May 13 9:40 PMSteven GannonDirector
Option Exercise
3,500$7.380(D)

View →